Cargando…

Yeast-Based Virus-like Particles as an Emerging Platform for Vaccine Development and Delivery

Virus-like particles (VLPs) are empty, nanoscale structures morphologically resembling viruses. Internal cavity, noninfectious, and particulate nature with a high density of repeating epitopes, make them an ideal platform for vaccine development and drug delivery. Commercial use of Gardasil-9 and Ce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Srivastava, Vartika, Nand, Kripa N., Ahmad, Aijaz, Kumar, Ravinder
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9965603/ https://www.ncbi.nlm.nih.gov/pubmed/36851356 http://dx.doi.org/10.3390/vaccines11020479

Ejemplares similares

Application of anti-fungal vaccines as a tool against emerging anti-fungal resistance
por: Kumar, Ravinder, et al.
Publicado: (2023)

Virus-like Particle Vaccines and Platforms for Vaccine Development
por: Kheirvari, Milad, et al.
Publicado: (2023)

Virus-Like Particles: Revolutionary Platforms for Developing Vaccines Against Emerging Infectious Diseases
por: Tariq, Hasnat, et al.
Publicado: (2022)

Abrogation of pathogenic attributes in drug resistant Candida auris strains by farnesol
por: Srivastava, Vartika, et al.
Publicado: (2020)

New perspective towards therapeutic regimen against SARS-CoV-2 infection
por: Srivastava, Vartika, et al.
Publicado: (2021)

Virus like particles as a platform for cancer vaccine development
por: Ong, Hui Kian, et al.
Publicado: (2017)

Developing a platform system for gene delivery: amplifying virus-like particles (AVLP) as an influenza vaccine
por: Wei, Huiling, et al.
Publicado: (2017)

Virus-Like Particles as an Immunogenic Platform for Cancer Vaccines
por: Caldeira, Jerri C., et al.
Publicado: (2020)

Lyophilized yeast powder for adjuvant free thermostable vaccine delivery
por: Kumar, Ravinder, et al.
Publicado: (2021)

Virus-Like Particles, a Versatile Subunit Vaccine Platform
por: Donaldson, Braeden, et al.
Publicado: (2014)

Platforms, advances, and technical challenges in virus-like particles-based vaccines
por: Gupta, Reeshu, et al.
Publicado: (2023)

A novel delivery platform based on Bacteriophage MS2 virus-like particles
por: Fu, Yu, et al.
Publicado: (2016)

Development of a Novel Virus-Like Particle Vaccine Platform That Mimics the Immature Form of Alphavirus
por: Urakami, Akane, et al.
Publicado: (2017)

Virus-like particles: the future of microbial factories and cell-free systems as platforms for vaccine development
por: Rodríguez-Limas, William A, et al.
Publicado: (2013)

Hepatitis B core-based virus-like particles: A platform for vaccine development in plants
por: Moradi Vahdat, Maryam, et al.
Publicado: (2021)

Flagellin/Virus-like Particle Hybrid Platform with High Immunogenicity, Safety, and Versatility for Vaccine Development
por: Zhao, Yiwen, et al.
Publicado: (2022)

Virus-Like Particles as a Vaccine Delivery System: Myths and Facts
por: Roy, Polly, et al.
Publicado: (2009)

Candida parapsilosis Cell Wall Proteome Characterization and Effectiveness against Hematogenously Disseminated Candidiasis in a Murine Model
por: Gong, Xiaolong, et al.
Publicado: (2023)

Epitope-Specific Anti-hCG Vaccines on a Virus Like Particle Platform
por: Caldeira, Jerri, et al.
Publicado: (2015)

Modular vaccine platform based on the norovirus-like particle
por: Lampinen, Vili, et al.
Publicado: (2021)

Virus like particle-based vaccines against emerging infectious disease viruses
por: Liu, Jinliang, et al.
Publicado: (2016)

Piperidine based 1,2,3-triazolylacetamide derivatives induce cell cycle arrest and apoptotic cell death in Candida auris
por: Srivastava, Vartika, et al.
Publicado: (2020)

Delivery of self-amplifying RNA vaccines in in vitro reconstituted virus-like particles
por: Biddlecome, Adam, et al.
Publicado: (2019)

The 3Ds in virus‐like particle based‐vaccines: “Design, Delivery and Dynamics”
por: Mohsen, Mona O., et al.
Publicado: (2020)

Exploiting virus-like particles as innovative vaccines against emerging viral infections
por: Jeong, Hotcherl, et al.
Publicado: (2017)

Expression and Characterization of Yeast Derived Chikungunya Virus Like Particles (CHIK-VLPs) and Its Evaluation as a Potential Vaccine Candidate
por: Saraswat, Shweta, et al.
Publicado: (2016)

Virus-like particles as a highly efficient vaccine platform: Diversity of targets and production systems and advances in clinical development
por: Kushnir, Natasha, et al.
Publicado: (2012)

Production of virus-like particles for vaccines
por: Fuenmayor, J., et al.
Publicado: (2017)

Virus-Like Particle and Nanoparticle Vaccines
por: Kanekiyo, M., et al.
Publicado: (2017)

Quantitative proteomic comparison of stationary/G(0) phase cells and tetrads in budding yeast
por: Kumar, Ravinder, et al.
Publicado: (2016)

Combinatorial evaluation of in vivo distribution of polyanhydride particle-based platforms for vaccine delivery
por: Petersen, Latrisha K, et al.
Publicado: (2013)

Advanced Antigen Delivery of Murine Survivin: Chimeric Virus-Like Particles in Cancer Vaccine Research
por: Schumacher, Thomas, et al.
Publicado: (2007)

Subviral particle as vaccine and vaccine platform
por: Tan, Ming, et al.
Publicado: (2014)

Hepatitis B Virus (HBV) Subviral Particles as Protective Vaccines and Vaccine Platforms
por: Ho, Joan Kha-Tu, et al.
Publicado: (2020)

Analytical technologies for influenza virus-like particle candidate vaccines: challenges and emerging approaches
por: Thompson, Christine M, et al.
Publicado: (2013)

A Modular Vaccine Development Platform Based on Sortase-Mediated Site-Specific Tagging of Antigens onto Virus-Like Particles
por: Tang, Shubing, et al.
Publicado: (2016)

Biogenic ZnO Nanoparticles Synthesized from Origanum vulgare Abrogates Quorum Sensing and Biofilm Formation in Opportunistic Pathogen Chromobacterium violaceum
por: Kamli, Majid Rasool, et al.
Publicado: (2021)

Escherichia coli-derived virus-like particles in vaccine development
por: Huang, Xiaofen, et al.
Publicado: (2017)

Virus-Like Particles and Nanoparticles for Vaccine Development against HCMV
por: Perotti, Michela, et al.
Publicado: (2019)

Vaccine Potential of Nipah Virus-Like Particles
por: Walpita, Pramila, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_2ngi288atnq9su1abvmhn0d113